Related Experiment Video
Updated: Feb 13, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
CSB: An Emerging Actionable Target for Cancer Therapy
Luca Proietti-De-Santis1, Alessio Balzerano1, Giorgio Prantera1
1Unit of Molecular Genetics of Aging and Laboratory of Epigenetics, Department of Ecology and Biology, University of Tuscia, 01100 Viterbo, Italy.
Cockayne syndrome group B (CSB) protein is overexpressed in cancer, promoting tumor growth. Suppressing CSB shows anticancer effects, suggesting CSB downregulation as a novel cancer therapy.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Research
Background:
- The DNA repair protein Cockayne syndrome group B (CSB) is overexpressed in various cancer types.
- Elevated CSB levels correlate with increased tumor cell proliferation and resistance to apoptosis.
- CSB plays a significant role in maintaining cancer cell viability and progression.
Purpose of the Study:
- To investigate the therapeutic potential of targeting CSB in cancer treatment.
- To evaluate the effects of CSB suppression on cancer cell behavior.
- To establish CSB downregulation as a viable anticancer strategy.
Main Methods:
- Analysis of CSB expression levels in cancer cells.
- Experimental manipulation of CSB levels (e.g., using gene silencing techniques).
- Assessment of cancer cell proliferation, apoptosis, and other relevant cancer hallmarks following CSB modulation.
Main Results:
- CSB is frequently overexpressed in cancer cells.
- High CSB levels promote tumor cell proliferation and inhibit apoptosis.
- Suppression of CSB significantly inhibits cancer cell growth and induces apoptosis, demonstrating anticancer effects.
Conclusions:
- CSB overexpression is a key factor in cancer progression.
- Downregulation of CSB exhibits potent anticancer activity.
- Targeting CSB represents a promising new therapeutic approach for cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Emerging Adulthood
Fixed Action Patterns
Introduction Cardiac Emergencies

